Jason H Peragallo1,2, Stephanie Keller3, Marjo S van der Knaap4, Bruno P Soares5, Suma P Shankar1,6,7. 1. a Department of Ophthalmology , Emory University , Atlanta , Georgia , USA. 2. b Department of Pediatrics , Emory University , Atlanta , Georgia , USA. 3. c Department of Neurology , Emory University , Atlanta , Georgia , USA. 4. d Department of Child Neurology , VU University Medical Center , Amsterdam , the Netherlands. 5. e Section of Pediatric Neuroradiology, Division of Pediatric Radiology, Russell H. Morgan Department of Radiology and Radiological Science , The Johns Hopkins University School of Medicine , Baltimore , Maryland , USA. 6. f Department of Human Genetics , Emory University , Atlanta , Georgia , USA. 7. g Division of Genomic Medicine , University of California Davis , Davis , California , USA.
Abstract
BACKGROUND: Optic atrophy may be the sequela of optic nerve injury due to any insult, including isolated and syndromic genetic diseases. Alanyl-tRNA synthetase 2 (AARS2) pathogenic variants have been reported to cause leukodystrophy with ovarian failure, and cardiomyopathy (#615889) as well as combined oxidative phosphorylation deficiency-8 (#614096). We report a young child who presented with decreased vision due to optic atrophy and was found to harbor missense variants in the AARS2 gene expanding the phenotypic expression of the AARS2 gene. MATERIALS AND METHODS: Single observational case report with genetic testing, laboratory testing, neurologic and ophthalmic clinical examinations, and neuroimaging performed at a tertiary academic medical center. RESULTS: An 18-month old Korean boy was noted to have a progressive decline in visual function. The physical exam revealed bilateral optic atrophy, peripheral retinal bone spicule pigmentation, and absent patellar reflexes. Electromyography was consistent with demyelinating polyneuropathy. Magnetic resonance imaging (MRI) of the brain and spine showed cerebellar and supratentorial white matter multifocal changes with areas of restricted diffusion, and dorsal column signal abnormalities. Whole exome sequencing revealed two missense variants in the AARS2 gene [c.1519G>C (p.V507L) and c.2165G>A (p.R722Q)], found to be in trans on parental testing. CONCLUSIONS: Missense variants in the AARS2 gene are the likely cause of the retinopathy and optic atrophy in this patient. This finding expands the phenotypic spectrum of the AARS2 gene.
BACKGROUND:Optic atrophy may be the sequela of optic nerve injury due to any insult, including isolated and syndromic genetic diseases. Alanyl-tRNA synthetase 2 (AARS2) pathogenic variants have been reported to cause leukodystrophy with ovarian failure, and cardiomyopathy (#615889) as well as combined oxidative phosphorylation deficiency-8 (#614096). We report a young child who presented with decreased vision due to optic atrophy and was found to harbor missense variants in the AARS2 gene expanding the phenotypic expression of the AARS2 gene. MATERIALS AND METHODS: Single observational case report with genetic testing, laboratory testing, neurologic and ophthalmic clinical examinations, and neuroimaging performed at a tertiary academic medical center. RESULTS: An 18-month old Korean boy was noted to have a progressive decline in visual function. The physical exam revealed bilateral optic atrophy, peripheral retinal bone spicule pigmentation, and absent patellar reflexes. Electromyography was consistent with demyelinating polyneuropathy. Magnetic resonance imaging (MRI) of the brain and spine showed cerebellar and supratentorial white matter multifocal changes with areas of restricted diffusion, and dorsal column signal abnormalities. Whole exome sequencing revealed two missense variants in the AARS2 gene [c.1519G>C (p.V507L) and c.2165G>A (p.R722Q)], found to be in trans on parental testing. CONCLUSIONS: Missense variants in the AARS2 gene are the likely cause of the retinopathy and optic atrophy in this patient. This finding expands the phenotypic spectrum of the AARS2 gene.
Authors: Małgorzata J M Nowaczyk; Lijia Huang; Mark Tarnopolsky; Jeremy Schwartzentruber; Jacek Majewski; Dennis E Bulman; Taila Hartley; Kym M Boycott Journal: Am J Med Genet A Date: 2016-09-15 Impact factor: 2.802
Authors: Stella Mazurova; Martin Magner; Vendula Kucerova-Vidrova; Alzbeta Vondrackova; Viktor Stranecky; Anna Pristoupilova; Josef Zamecnik; Hana Hansikova; Jiri Zeman; Marketa Tesarova; Tomas Honzik Journal: Cardiol Young Date: 2016-11-14 Impact factor: 1.093
Authors: Alexandra Götz; Henna Tyynismaa; Liliya Euro; Pekka Ellonen; Tuulia Hyötyläinen; Tiina Ojala; Riikka H Hämäläinen; Johanna Tommiska; Taneli Raivio; Matej Oresic; Riitta Karikoski; Outi Tammela; Kalle O J Simola; Anders Paetau; Tiina Tyni; Anu Suomalainen Journal: Am J Hum Genet Date: 2011-05-05 Impact factor: 11.025
Authors: David S Lynch; Wei Jia Zhang; Rahul Lakshmanan; Justin A Kinsella; Günes Altiokka Uzun; Merih Karbay; Zeynep Tüfekçioglu; Hasmet Hanagasi; Georgina Burke; Nicola Foulds; Simon R Hammans; Anupam Bhattacharjee; Heather Wilson; Matthew Adams; Mark Walker; James A R Nicoll; Jeremy Chataway; Nick Fox; Indran Davagnanam; Rahul Phadke; Henry Houlden Journal: JAMA Neurol Date: 2016-12-01 Impact factor: 18.302
Authors: Robert W Taylor; Angela Pyle; Helen Griffin; Emma L Blakely; Jennifer Duff; Langping He; Tania Smertenko; Charlotte L Alston; Vivienne C Neeve; Andrew Best; John W Yarham; Janbernd Kirschner; Ulrike Schara; Beril Talim; Haluk Topaloglu; Ivo Baric; Elke Holinski-Feder; Angela Abicht; Birgit Czermin; Stephanie Kleinle; Andrew A M Morris; Grace Vassallo; Grainne S Gorman; Venkateswaran Ramesh; Douglass M Turnbull; Mauro Santibanez-Koref; Robert McFarland; Rita Horvath; Patrick F Chinnery Journal: JAMA Date: 2014-07-02 Impact factor: 56.272
Authors: Cristina Dallabona; Daria Diodato; Sietske H Kevelam; Tobias B Haack; Lee-Jun Wong; Gajja S Salomons; Enrico Baruffini; Laura Melchionda; Caterina Mariotti; Tim M Strom; Thomas Meitinger; Holger Prokisch; Kim Chapman; Alison Colley; Helena Rocha; Katrin Ounap; Raphael Schiffmann; Ettore Salsano; Mario Savoiardo; Eline M Hamilton; Truus E M Abbink; Nicole I Wolf; Ileana Ferrero; Costanza Lamperti; Massimo Zeviani; Adeline Vanderver; Daniele Ghezzi; Marjo S van der Knaap Journal: Neurology Date: 2014-05-07 Impact factor: 9.910
Authors: Sahyli Perez Parra; Stephan H Heckers; William R Wilcox; Colin David Mcknight; H A Jinnah Journal: Parkinsonism Relat Disord Date: 2021-11-10 Impact factor: 4.891
Authors: Anna Tracewska-Siemiątkowska; Lonneke Haer-Wigman; Danielle G M Bosch; Deborah Nickerson; Michael J Bamshad; Maartje van de Vorst; Nanna Dahl Rendtorff; Claes Möller; Ulrika Kjellström; Sten Andréasson; Frans P M Cremers; Lisbeth Tranebjærg Journal: Genes (Basel) Date: 2017-12-11 Impact factor: 4.096
Authors: Hadley Stevens Smith; J Michael Swint; Seema R Lalani; Jose-Miguel Yamal; Marcia C de Oliveira Otto; Stephan Castellanos; Amy Taylor; Brendan H Lee; Heidi V Russell Journal: Genet Med Date: 2018-05-14 Impact factor: 8.822